Omega Diagnostics Share Discussion Threads

[boonkoh] 23/4/2018 09:46

Guess we won't get any imminent CD4 approval news or new market news soon, seeing how the Group FD has just purchased.

[barrywhit] 23/4/2018 08:26

Overhang finally gone, normal trading pattern back...

[euclid5] 21/4/2018 19:08

"the successful completion of the CE-Mark process means these tests, which indicate whether a person's CD4 count is higher or lower than 350 cells/mm³, are available for general sale through business to business channels in countries not requiring individual product registration. The technical file forms the basis of the additional regulatory approval the Company will seek through the World Health Organisation Prequalification programme which assesses in vitro diagnostics tests for priority diseases and their suitability for use in resource-limited settings.

A successful completion of this process will enable Omega to become eligible for public sector procurement. The Company anticipates that this process is likely to be completed during the second half of the next financial year"

[jeevsje] 20/4/2018 23:57

Funnily enough that 4.5million and 0.5million adds up to 5million, which coincidentally belongs to Mill's Harwood. Monday's RNS should be fun. I have a feeling we could see twenties earlier than anticipated. The board's departure itself will send us into the thirties.
Alternatively, someone is accumulating prior to a bid. Someone competent would make a killing out of CD4.

[longshanks] 20/4/2018 22:03

Fighting talk hyper.I like it.

[hyperboreus] 20/4/2018 21:51

Well usually I agree with you p1nkfish but not on this occasion however as I would never ever trust any organistation that issues a trading update at close of play on a Friday afternoon, absolute shysters from my standpoint.

It would appear to me that Immunodiagnostic Systems or IDS as they like to call themselves are about as clueless and trustworthy as our lot, no wonder it took nearly 18 months to sort the so called distribution agreement out.

Anyhow that non event is really irrelevant to me now as it would appear the most pertinent happening today is the volume of 10,320,600 shares traded equating to around 8% of total shares in issue, which I do not believe I have seen whilst I have been an ODX shareholder during the past 6 years.

The ODX RNS clearly has very little to do with the rise in share price but the 4.5 million x 2 trades @ 08:39hrs followed by the 0.5 million @ 08:58hrs this morning are intriguing.

It is all conjecture until a formal announcement is made but I would think and longingly hope that an external third party has taken an interest in proceedings here.

Hopefully the 'Balls Up Investor Presentation Jobby' on 21 May 2018 when no new information will be disclosed will not be necessary as Messrs King, Harbinson & Grewal will looking for alternative employment!

Have a great weekend 😝

[p1nkfish] 20/4/2018 19:36

It makes me wonder if the delay in signing IDH was down to IDH being realistic, why bother for moderate upside, and it has now occurred in order to assist ODX.

The IDH text reads as very straight, clear and with a deep realism. Creditable.

[longshanks] 20/4/2018 19:28

Interesting comparison of narrative between the IDH and ODX releases.From IDH it is clear that they are quite ambivalent about Allersys. The limited range of allergens makes it unsuitable for sales activity aimed at replacing competitor systems, but they seem happy to have secured exclusive global distribution rights without having to spend much on it.For ODX, the best they can hope for is some sales from existing users of the assay apparatus that want to branch into allergy testing: a very limited market I imagine. ODX need to expand the menu to over 100 allergens. That will take more money than they have to hand.IMO, the ODX RNS dissembled the clear limitations of the agreement with a view to misleading shareholders. It makes me quite angry.The more I read, the more amateur and misguided the product development team appear to be: compounded by a sales force with no grip on what the market actually wants and a board of directors with no moral fibre. They have already said that the CD4 test needs to be adapted to cater for a different measurement: how long before they fess up that the original product has no viable market and they can't get the test to work at the new sensitivity level.

[hyperboreus] 20/4/2018 18:08

Interesting that IDS issued a lacklustre trading update clearly trying to bury bad news at closing time, 16:35hrs precisely.

The following extract relates to our beloved Omega:

6. Automated Business - New Allergy Products
We are pleased to announce that we have recently signed an exclusive agreement to distribute globally 51 allergy assays which have been developed by our partner, Omega Diagnostics. These assays will be branded as IDS Allersys.

We only anticipate modest revenues from these assays in the next 1 - 2 years, as a much larger panel of assays, and related screening tests, are required to place new analyzers in labs with a focus on allergy testing. The incumbent providers feature menus with over 100 tests. Revenues in the next couple of years will thus largely be limited to upsells into the existing IDS analyzer installations. Encouragingly feedback from initial trials is that the IDS / Omega solution is more flexible and easy to use than existing systems available for small to mid-size laboratories.

I'm hoping that Omega issue another RNS on Monday regarding anything really as long as it mentions a prediction containing more modest growth! 😁

[barrywhit] 20/4/2018 16:25

Well we have clawed back a little.........

[barrywhit] 20/4/2018 14:24

buying 4,500,000 shares at 9.2685 ?

[buywell3] 20/4/2018 14:04

Selling 4,500,000 shares at 9.25p ?

[barrywhit] 20/4/2018 11:15

I would still like to see an updated share register to see if any large holders have gone, or the majority of selling was small P.I's.....

[buywell3] 20/4/2018 10:03

added

Latest trades
Time Price Volume Value
10:42:37 10.5 838 88




calm down boonkoh , ramping this at the moment is not justified IMO
08:39:17 9.25 4,500,000 416,250



Funny isn't it , that with ODX now hamstrung tradingwise and with cash running low, £100k , that we get an RNS today re IDS.


I think that ODX are desperate.

IDS IMO will have had the whip hand in the deal announced regarding the financial terms , a deal that has been talked about for the last year and longer.

I go further

IMO ODX will have signed just about anything yesterday to get any positive newsflow to counteract the negative market sentiment that has beset the share price chart.

why ?

The RNS just might get some to stump up some cash when the hat gets passed around

I still think loan notes in days cometh.

dyor

[boonkoh] 20/4/2018 09:11

Market thinks its overhang, now above 10p

[rivaldo] 20/4/2018 08:46

Good news that the deal is finally agreed. It does seem odd however to expect only modest growth in the short-term - given that the deal has been on the cards for so long, shouldn't the respective parties have been planning for launch for some time and got a handle on the marketing etc already?

I see two lots of 4.5m shares have just gone through. Clearance of an overhang? Or just a rollover?

[p1nkfish] 20/4/2018 08:25

Why only modest growth?
Demand problem or what?
Lack of sales and marketing budget?
Needs more colour on the announcement.

[longshanks] 20/4/2018 07:28

No RNS from IDH to "celebrate" this partnership. Equally, no commercial details have been disclosed other than a statement that only modest initial sales are expected.I am uncomfortable holding a cynical view, but this news just seems a little too limp and a little too late to alter the gaping wound represented by the company's current balance sheet."Could do better" in red ink is what I see written all over this effort.

[barrywhit] 20/4/2018 07:23

Good to see the IDS deal finally signed...

[hyperboreus] 20/4/2018 07:04

Finally the Distribution Agreement with IDS has been signed off:

[p1nkfish] 20/4/2018 01:24

Will be away so no chance of going.
Frankly, will it make any difference?
An external independent valuation of the parts would help.

[arthur_lame_stocks] 19/4/2018 22:45

Just noticed it's light refreshments only. TRT gave me a few glasses of wine.

It'll be the most expensive canape i've ever had.

[arthur_lame_stocks] 19/4/2018 20:31

Is anyone going to go to the Investor Presentation? I may go along as it's convenient for me although why they couldn't make it a bit later so that people can go after work I don't know.

[barrywhit] 19/4/2018 13:34

RNS Number : 4873L

Omega Diagnostics Group PLC

19 April 2018


Omega Diagnostics Group PLC

("Omega" or "the Company" or the "Group")

Investor Evening

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces it will be hosting an investor evening for all investors on Monday 21 May 2018.

Colin King, CEO will give an update on the Group's core business activities following the recent announcement of a strategic review. He will be joined by Kieron Harbinson, FD, and Jag Grewal, Group Sales and Marketing Director. The presentation and Q&A will last approximately 60 minutes.

The event will take place in the Copper Bar, upstairs at Balls Brothers, 6 Adams Court, Old Broad St, London, EC2N 1DX at 4.30pm for a 4.45pm start. This will be followed by light refreshments, and a chance to network.

The presentation slides will be available on the Company website shortly after the event. No new information will be disclosed.

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email [e-mail].

[jeevsje] 19/4/2018 11:56

Rotten eggs and vegetables ready for 21st May.